![Ellen Rose](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ellen Rose
Investor Relations Contact bij
LB PHARMACEUTICALS INC
Profiel
Ellen Rose is Senior Vice President-Corporate Affairs at LB Pharmaceuticals, Inc. since 2026.
Former roles include Director-Communications at ALZA Corp., Head-Communications & Media Relations at Prothena Corp.
Plc, and Senior VP-Communications & Investor Relations at Lyell Immunopharma, Inc. Education includes undergraduate studies at Stanford University.
Actieve functies van Ellen Rose
| Bedrijven | Functie | Begin |
|---|---|---|
| LB PHARMACEUTICALS INC | Investor Relations Contact | 06-01-2026 |
Eerdere bekende functies van Ellen Rose
| Bedrijven | Functie | Einde |
|---|---|---|
| LYELL IMMUNOPHARMA, INC. | Investor Relations Contact | - |
| ALZA CORPORATION | Public Communications Contact | - |
| PROTHENA CORPORATION PLC | Public Communications Contact | - |
Opleiding van Ellen Rose
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
3
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology Provides and develops pharmaceutical products | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prothena Corp. Plc
 Prothena Corp. Plc BiotechnologyHealth Technology Focuses on the discovery and development of novel antibodies | Health Technology |
LB Pharmaceuticals, Inc.
 LB Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression and neuropsychiatric diseases | Health Technology |
Lyell Immunopharma, Inc.
 Lyell Immunopharma, Inc. BiotechnologyHealth Technology Develops cell-based immunotherapies for human diseases | Health Technology |
